Home / MissionIR Articles / Vical, Inc. (VICL) Starts Presentation at 25th Annual ROTH Conference

Vical, Inc. (VICL) Starts Presentation at 25th Annual ROTH Conference

Vical researches and develops biopharmaceutical products based on the company’s patented DNA delivery technologies for the prevention and treatment of serious or life-threatening diseases. Potential applications of the company’s DNA delivery technology include DNA vaccines for infectious diseases or cancer; cancer immunotherapeutics; and cardiovascular therapies. The company is developing certain infectious disease vaccines and cancer therapeutics internally. For more information, visit the company’s Web site: http://www.vical.com

Let us hear your thoughts below: